AAAAAA

   
Results: 1-21 |
Results: 21
ALGLUCERASE - PRACTICAL GUIDANCE ON APPROPRIATE DOSAGE AND ADMINISTRATION IN PATIENTS WITH GAUCHER-DISEASE
Authors: HOLLAK CEM AERTS JMFG VANOERS NHJ
Citation: Cem. Hollak et al., ALGLUCERASE - PRACTICAL GUIDANCE ON APPROPRIATE DOSAGE AND ADMINISTRATION IN PATIENTS WITH GAUCHER-DISEASE, Biodrugs, 9(1), 1998, pp. 11-23
OLIGOSACCHARIDE EXCRETION IN ADULT GAUCHER-DISEASE
Authors: DEJONG JGN AERTS JMFG VANWEELY S HOLLAK CEM VANPELT J VANWOERKOM LMJ LIEBRANDVANSAMBEEK MLF WEVERS RA
Citation: Jgn. Dejong et al., OLIGOSACCHARIDE EXCRETION IN ADULT GAUCHER-DISEASE, Journal of inherited metabolic disease, 21(1), 1998, pp. 49-59
ELEVATED LEVELS OF M-CSF, SCD14 AND IL8 IN TYPE-1 GAUCHER-DISEASE
Authors: HOLLAK CEM EVERS L AERTS JMFG VANOERS MHJ
Citation: Cem. Hollak et al., ELEVATED LEVELS OF M-CSF, SCD14 AND IL8 IN TYPE-1 GAUCHER-DISEASE, Blood cells, molecules, & diseases, 23(11), 1997, pp. 201-212
GLUCOCEREBROSIDASE GENOTYPE OF GAUCHER PATIENTS IN THE NETHERLANDS - LIMITATIONS IN PROGNOSTIC VALUE
Authors: BOOT RG HOLLAK CEM VERHOEK M SLOOF P POORTHUIS BJHM KLEIJER WJ WEVERS RA VANOERS MHJ MANNENS MMAM AERTS JMFG VANWEELY S
Citation: Rg. Boot et al., GLUCOCEREBROSIDASE GENOTYPE OF GAUCHER PATIENTS IN THE NETHERLANDS - LIMITATIONS IN PROGNOSTIC VALUE, Human mutation, 10(5), 1997, pp. 348-358
PLASMA AND METABOLIC ABNORMALITIES IN GAUCHERS-DISEASE
Authors: AERTS JMFG HOLLAK CEM
Citation: Jmfg. Aerts et Cem. Hollak, PLASMA AND METABOLIC ABNORMALITIES IN GAUCHERS-DISEASE, Bailliere's clinical haematology, 10(4), 1997, pp. 691-709
COAGULATION ABNORMALITIES IN TYPE-1 GAUCHER-DISEASE ARE DUE TO LOW-GRADE ACTIVATION AND CAN BE PARTLY RESTORED BY ENZYME SUPPLEMENTATION THERAPY
Authors: HOLLAK CEM LEVI M BERENDS F AERTS JMFG VANOERS MHJ
Citation: Cem. Hollak et al., COAGULATION ABNORMALITIES IN TYPE-1 GAUCHER-DISEASE ARE DUE TO LOW-GRADE ACTIVATION AND CAN BE PARTLY RESTORED BY ENZYME SUPPLEMENTATION THERAPY, British Journal of Haematology, 96(3), 1997, pp. 470-476
LEVELS OF THROMBOPOIETIN (TPO) ARE ELEVATED IN SPLENECTOMIZED GAUCHER-DISEASE (GD) PATIENTS AND MAY REFLECT BONE-MARROW INFILTRATION
Authors: HOLLAK CEM MAAS M LINTHORST G VANOERS MHJ AERTS JMFG VONDEMBORNE AEGK
Citation: Cem. Hollak et al., LEVELS OF THROMBOPOIETIN (TPO) ARE ELEVATED IN SPLENECTOMIZED GAUCHER-DISEASE (GD) PATIENTS AND MAY REFLECT BONE-MARROW INFILTRATION, Blood, 90(10), 1997, pp. 624-624
DIFFERENTIAL-EFFECTS OF ENZYME SUPPLEMENTATION THERAPY ON MANIFESTATIONS OF TYPE-1 GAUCHER-DISEASE
Authors: HOLLAK CEM CORSSMIT EPM AERTS JMFG ENDERT E SAUERWEIN HP ROMIJN JA VANOERS MHJ
Citation: Cem. Hollak et al., DIFFERENTIAL-EFFECTS OF ENZYME SUPPLEMENTATION THERAPY ON MANIFESTATIONS OF TYPE-1 GAUCHER-DISEASE, The American journal of medicine, 103(3), 1997, pp. 185-191
ALGLUCERASE (CEREDASE(TM))
Authors: WILTINK EHH HOLLAK CEM
Citation: Ehh. Wiltink et Cem. Hollak, ALGLUCERASE (CEREDASE(TM)), Pharmacy world & science, 18(1), 1996, pp. 16-19
PLASMA TUMOR NECROSIS FACTOR-A (TNF-A) LEVELS IN GAUCHER DISEASE
Authors: MICHELAKAKIS H SPANOU C KONDYLI A DIMITRIOU E VANWEELY S HOLLAK CEM VANOERS MHJ AERTS JMFG
Citation: H. Michelakakis et al., PLASMA TUMOR NECROSIS FACTOR-A (TNF-A) LEVELS IN GAUCHER DISEASE, Biochimica et biophysica acta. Molecular basis of disease, 1317(3), 1996, pp. 219-222
THE EFFECT OF ENZYME THERAPY IN A PATIENT WITH GAUCHER DISEASE TYPE-III
Authors: BOSMAN DK HOLLAK CEM AERTS JMFG BAKKER HD
Citation: Dk. Bosman et al., THE EFFECT OF ENZYME THERAPY IN A PATIENT WITH GAUCHER DISEASE TYPE-III, Journal of inherited metabolic disease, 19(5), 1996, pp. 703-704
LOW-DOSE VERSUS HIGH-FREQUENCY REGIMENS IN GAUCHERS-DISEASE
Authors: HOLLAK CEM GOUDSMIT R VANOERS MHJ
Citation: Cem. Hollak et al., LOW-DOSE VERSUS HIGH-FREQUENCY REGIMENS IN GAUCHERS-DISEASE, Lancet, 347(8998), 1996, pp. 406-407
ELEVATED PLASMA CHITOTRIOSIDASE ACTIVITY IN VARIOUS LYSOSOMAL STORAGEDISORDERS
Authors: GUO YF HE W BOER AM WEVERS RA DEBRUIJN AM GROENER JEMM HOLLAK CEM AERTS JMFG GALJAARD H VANDIGGELEN OP
Citation: Yf. Guo et al., ELEVATED PLASMA CHITOTRIOSIDASE ACTIVITY IN VARIOUS LYSOSOMAL STORAGEDISORDERS, Journal of inherited metabolic disease, 18(6), 1995, pp. 717-722
INDIVIDUALIZED LOW-DOSE ALGLUCERASE THERAPY FOR TYPE-1 GAUCHERS-DISEASE
Authors: HOLLAK CEM AERTS JMFG GOUDSMIT R PHOA SSKS EK M VANWEELY S VONDEMBORNE AEGK VANOERS MHJ
Citation: Cem. Hollak et al., INDIVIDUALIZED LOW-DOSE ALGLUCERASE THERAPY FOR TYPE-1 GAUCHERS-DISEASE, Lancet, 345(8963), 1995, pp. 1474-1478
INCREASED BASAL GLUCOSE-PRODUCTION IN TYPE-1 GAUCHERS-DISEASE
Authors: CORSSMIT EPM HOLLAK CEM ENDERT E VANOERS MHJ SAUERWEIN HP ROMIJN JA
Citation: Epm. Corssmit et al., INCREASED BASAL GLUCOSE-PRODUCTION IN TYPE-1 GAUCHERS-DISEASE, The Journal of clinical endocrinology and metabolism, 80(9), 1995, pp. 2653-2657
MARKED ELEVATION OF PLASMA CHITOTRIOSIDASE ACTIVITY - A NOVEL HALLMARK OF GAUCHER DISEASE
Authors: HOLLAK CEM VANWEELY S VANOERS MHJ AERTS JMFG
Citation: Cem. Hollak et al., MARKED ELEVATION OF PLASMA CHITOTRIOSIDASE ACTIVITY - A NOVEL HALLMARK OF GAUCHER DISEASE, The Journal of clinical investigation, 93(3), 1994, pp. 1288-1292
SEVERE COAGULATION DISORDERS IN TYPE-1 GAUCHER DISEASE
Authors: HOLLAK CEM LEVI M VONDEMBORNE AEGK BERENDS F VANOERS MHJ
Citation: Cem. Hollak et al., SEVERE COAGULATION DISORDERS IN TYPE-1 GAUCHER DISEASE, Blood, 84(10), 1994, pp. 10000677-10000677
PATHOGENESIS OF LYSOSOMAL STORAGE DISORDERS AS ILLUSTRATED BY GAUCHERDISEASE
Authors: AERTS JMFG VANWEELY S BOOT R HOLLAK CEM TAGER JM
Citation: Jmfg. Aerts et al., PATHOGENESIS OF LYSOSOMAL STORAGE DISORDERS AS ILLUSTRATED BY GAUCHERDISEASE, Journal of inherited metabolic disease, 16(2), 1993, pp. 288-291
TREATMENT OF GAUCHERS-DISEASE
Authors: HOLLAK CEM AERTS JMFG VANOERS MHJ
Citation: Cem. Hollak et al., TREATMENT OF GAUCHERS-DISEASE, The New England journal of medicine, 328(21), 1993, pp. 1565-1566
HOME TREATMENT WITH INTRAVENOUS ENZYME REPLACEMENT THERAPY FOR GAUCHER DISEASE - AN INTERNATIONAL COLLABORATIVE STUDY OF 33 PATIENTS
Authors: ZIMRAN A HOLLAK CEM ABRAHAMOV A VANOERS MHJ KELLY M BEUTLER E
Citation: A. Zimran et al., HOME TREATMENT WITH INTRAVENOUS ENZYME REPLACEMENT THERAPY FOR GAUCHER DISEASE - AN INTERNATIONAL COLLABORATIVE STUDY OF 33 PATIENTS, Blood, 82(4), 1993, pp. 1107-1109
ENZYME SUPPLETION THERAPY FOR TYPE-1 GAUCHER DISEASE - EFFICACY OF VERY-LOW DOSE ALGLUCERASE IN 12 PATIENTS
Authors: HOLLAK CEM AERTS JMFG VANWEELY S PHOA SSKS GOUDSMIT R VONDEMBORNE AEGK VANOERS MHJ
Citation: Cem. Hollak et al., ENZYME SUPPLETION THERAPY FOR TYPE-1 GAUCHER DISEASE - EFFICACY OF VERY-LOW DOSE ALGLUCERASE IN 12 PATIENTS, Blood, 82(10), 1993, pp. 10000033-10000033
Risultati: 1-21 |